Literature DB >> 15133592

Is the excess risk of psychosis-like experiences in urban areas attributable to altered cognitive development?

N C Stefanis1, Ph Delespaul, N Smyrnis, A Lembesi, D A Avramopoulos, I K Evdokimidis, C N Stefanis, J van Os.   

Abstract

BACKGROUND: Rates of psychotic disorder and related attenuated psychotic experiences are higher in urban areas. We examined to what degree differences between urban and rural areas could be attributed to differences in cognitive development.
METHOD: Scores on the nine subscales of the schizotypal personality questionnaire (SPQ) as well as IQ and specific neuropsychological functions of memory and attention were assessed in a representative sample of 943 young army conscripts from the 49 counties of Greece.
RESULTS: Young men from urban areas had higher scores on the SPQ subscale Odd beliefs/magical thinking (OR = 1.99, 95% CI: 1.42, 2.78), but lower scores on Excessive social anxiety (OR = 0.63, 95 % CI: 0.49, 0.81) and No close friends (OR = 0.42, 95% CI: 0.29, 0.62). Adjustment for demographic factors, IQ and specific neuropsychological functions did not change the results. When the lower scores on Excessive social anxiety and No close friends were taken into account, the differences on the Odd beliefs/magical thinking subscale became even more pronounced (OR = 2.33, 95% CI: 1.56, 3.49).
CONCLUSIONS: Young men from urban areas are socially more competent, but display higher levels of positive psychotic experiences, which are not mediated by lower IQ or higher levels of neuropsychological impairment.

Entities:  

Mesh:

Year:  2004        PMID: 15133592     DOI: 10.1007/s00127-004-0771-3

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  8 in total

1.  Social disadvantage and schizophrenia. A combined neighbourhood and individual-level analysis.

Authors:  Marjan Drukker; Lydia Krabbendam; Ger Driessen; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-02       Impact factor: 4.328

2.  Evidence That the Urban Environment Moderates the Level of Familial Clustering of Positive Psychotic Symptoms.

Authors:  Anton Grech; Jim van Os
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

3.  Total exposure duration and proximity of cessation of cannabis use predict severity of sub-clinical psychotic symptoms among former users.

Authors:  Bora Baskak; Kerim Munir; Halise Devrimci Ozguven; Ersin Koc; Gulumser Gedik; Derya Erkan; Cem E Atbasoglu
Journal:  Psychiatry Res       Date:  2012-03-20       Impact factor: 3.222

4.  Equity in Mental Health Services for Youth at Clinical High Risk for Psychosis: Considering Marginalized Identities and Stressors.

Authors:  Joseph S DeLuca; Derek M Novacek; Laura H Adery; Shaynna N Herrera; Yulia Landa; Cheryl M Corcoran; Elaine F Walker
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2022-03-23

5.  Additive Effects of Former Methylenedioxymethamphetamine and Cannabis Use on Subclinical Psychotic Symptoms.

Authors:  Berker Duman; Nilay Sedes; Bora Baskak
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

6.  Testing the key assumption of heritability estimates based on genome-wide genetic relatedness.

Authors:  Dalton Conley; Mark L Siegal; Benjamin W Domingue; Kathleen Mullan Harris; Matthew B McQueen; Jason D Boardman
Journal:  J Hum Genet       Date:  2014-03-06       Impact factor: 3.172

7.  Neighborhood Characteristics at Birth and Positive and Negative Psychotic Symptoms in Adolescence: Findings From the ALSPAC Birth Cohort.

Authors:  Francesca Solmi; Glyn Lewis; Stanley Zammit; James B Kirkbride
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

8.  The Amsterdam Studies of Acute Psychiatry - II (ASAP-II): a comparative study of psychiatric intensive care units in the Netherlands.

Authors:  Vincent Koppelmans; Robert Schoevers; Cecile Gijsbers van Wijk; Wijnand Mulder; Annett Hornbach; Emile Barkhof; André Klaassen; Marieke van Egmond; Janine van Venrooij; Yan Bijpost; Hans Nusselder; Marjan van Herrewaarden; Igor Maksimovic; Alexander Achilles; Jack Dekker
Journal:  BMC Public Health       Date:  2009-09-03       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.